Classical Hodgkin lymphoma · 4 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Sirolimus and Vorinostat Variant #01 Partial | — | R 15 126 | 28d | — | — | ~3 | ~R 45 379 indirect | — |
Doxorubicin and Lomustine Variant #01 Partial | — | R 1 127 | 42d | — | — | ~5 | ~R 5 635 indirect | — |
Panobinostat monotherapy Variant #01 Partial | — | — | 21d | — | — | ~2 | — | — |
Carmustine monotherapy Variant #01 Partial | — | — | 42d | — | — | ~1 | — | — |
4 of 4 regimens shown